SCREENING OF MIGRANTS FOR CHRONIC HEPATITIS B VIRUS INFECTION: A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Veldhuijzen, I. K. [1 ]
Toy, M. [2 ]
Hahne, S. [3 ]
De Wit, G. A. [3 ]
Schalm, S. W. [2 ]
de Man, R. [4 ]
Richardus, J. H. [2 ]
机构：
[1] Municipal Publ Hlth Serv Rotterdam, Rotterdam, Zuid Holland, Netherlands
[2] Erasmus Univ, Med Ctr, Rotterdam, Zuid Holland, Netherlands
[3] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands
[4] Erasmus MC, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
来源：
VALUE IN HEALTH | 2009年 / 12卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(10)75094-4
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A424 / A424
页数：1
相关论文
共 50 条
  • [1] Treatment alternatives for chronic hepatitis B virus infection: A cost-effectiveness analysis
    Kanwal, F
    Gralnek, AM
    Martin, P
    Dulai, GS
    Farid, M
    Spiegel, BMR
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) : 821 - 831
  • [2] The Cost-effectiveness of Screening for Chronic Hepatitis B Infection in the United States
    Eckman, Mark H.
    Kaiser, Tiffany E.
    Sherman, Kenneth E.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (11) : 1294 - 1306
  • [3] Cost-effectiveness of universal screening for chronic hepatitis B virus infection in China: an economic evaluation
    Su, Shu
    Wong, William Cw
    Zou, Zhuoru
    Cheng, Dan Dan
    Ong, Jason J.
    Chan, Polin
    Ji, Fanpu
    Yuen, Man-Fung
    Zhuang, Guihua
    Seto, Wai-Kay
    Zhang, Lei
    [J]. LANCET GLOBAL HEALTH, 2022, 10 (02): : E278 - E287
  • [4] Screening for hepatitis B virus (HBV) prior to chemotherapy: A cost-effectiveness analysis
    Zurawska, U.
    Hicks, L. K.
    Woo, G.
    Bell, C. M.
    Krahn, M.
    Chan, K. K.
    Feld, J. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [5] SCREENING FOR HEPATITIS B VIRUS (HBV) PRIOR TO CHEMOTHERAPY: A COST-EFFECTIVENESS ANALYSIS
    Zurawska, Urszula
    Hicks, Lisa K.
    Woo, Gloria
    Bell, Chaim
    Krahn, Murray
    Chan, Kelvin
    Feld, Jordan J.
    [J]. HEPATOLOGY, 2011, 54 : 601A - 602A
  • [6] Hepatitis B Virus Screening Before Chemotherapy for Lymphoma: A Cost-Effectiveness Analysis
    Zurawska, Urszula
    Hicks, Lisa K.
    Woo, Gloria
    Bell, Chaim M.
    Krahn, Murray
    Chan, Kelvin K.
    Feld, Jordan J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (26) : 3167 - 3173
  • [7] Screening and Early Treatment of Migrants for Chronic Hepatitis B Virus Infection Is Cost-Effective
    Veldhuijzen, Irene K.
    Toy, Mehlika
    Hahne, Susan J. M.
    de Wit, G. Ardine
    Schalm, Solko W.
    de Man, Robert A.
    Richardus, Jan Hendrik
    [J]. GASTROENTEROLOGY, 2010, 138 (02) : 522 - 530
  • [8] Screening for Latent Tuberculosis Infection in Migrants With CKD: A Cost-effectiveness Analysis
    Campbell, Jonathon R.
    Johnston, James C.
    Ronald, Lisa A.
    Sadatsafavi, Mohsen
    Balshaw, Robert F.
    Cook, Victoria J.
    Levin, Adeera
    Marra, Fawziah
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (01) : 39 - 50
  • [9] The Effectiveness and Cost-Effectiveness of Screening for and Vaccination Against Hepatitis B Virus among Migrants in the EU/EEA: A Systematic Review
    Myran, Daniel T.
    Morton, Rachael
    Biggs, Beverly-Ann
    Veldhuijzen, Irene
    Castelli, Francesco
    Anh Tran
    Staub, Lukas P.
    Agbata, Eric
    Rahman, Prinon
    Pareek, Manish
    Noori, Teymur
    Pottie, Kevin
    [J]. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2018, 15 (09)
  • [10] Estimating the cost-effectiveness of screening for hepatitis C virus infection in Japan
    Nagai, Kota
    Ide, Kazuki
    Kawasaki, Yohei
    Tanaka-Mizuno, Sachiko
    Seto, Kahori
    Iwane, Shinji
    Eguchi, Yuichiro
    Kawakami, Koji
    [J]. HEPATOLOGY RESEARCH, 2020, 50 (05) : 542 - 556
12345